Shandong Keyuan Pharmaceutical Co.,Ltd.
Shandong Keyuan Pharmaceutical Co., Ltd. (Stock Code: 301281.SZ) was established in 2004. It is a leading enterprise in the chemical raw material medicine segment in China, practicing the core values of long-termism, product-ism, and altruism. Upholding the mission of "caring for life and health, guarding a better life," and practicing the core values of product-ism, long-termism, and altruism, we focus on providing high-quality pharmaceutical and health solutions for patients worldwide. On April 4, 2023, Keyuan Pharmaceutical successfully listed on the Shenzhen Stock Exchange's ChiNext board. With the support of capital, the company is making efforts in both domestic and international markets, and its business scope has expanded to dozens of countries and regions worldwide.
Company Establishment Time
Stock Code
Professional and technical personnel
Products are available nationwide
Focus on Core Tracks, Explore Diversified Growth
In the face of industry changes and challenges, Keyuan Pharmaceutical uses the fusion and innovation of chemical and biological synthesis technologies as its driving force, continuously strengthening its competitive advantages in the fields of anti-diabetic, cardiovascular, and central nervous system chronic diseases. At the same time, it actively expands into emerging business areas such as cosmetic raw materials, high-end pharmaceutical excipients, and functional food additives, building an industrial ecosystem of "raw materials + multi-field synergy. Its wholly-owned subsidiary, Shandong LINO Pharmaceutical Co., Ltd., focuses on the R&D, production, and sales of chemical pharmaceutical preparations. It has established a rich product line in the field of chronic diseases and accumulated strong R&D capabilities. Keyuan Pharmaceutical, together with LINO Pharmaceutical, has built a complete industrial system that integrates raw materials and preparations, excipients and preparations, and the entire upstream and downstream chain, gradually expanding its market competitive advantages.
Technology-Driven, Innovation Breakthrough
Keyuan Pharmaceutical regards technological R&D as its lifeline and has built a dual-wheel R&D system of "independent R&D + external collaboration. Internally, relying on R&D platforms such as the provincial-level enterprise technology center and the postdoctoral innovation practice base, it has built an international R&D team, focusing on breakthroughs in key technological areas such as green synthesis technology, preparation improvement, and biotechnology applications; Externally, it conducts in-depth cooperation with top institutions such as Beijing Nuokangda (strategic holding), Shanghai WuXi AppTec, and Shandong University to accelerate the transformation of technological achievements. In 2023, Keyuan and Nuokangda jointly built a Beijing R&D base to further strengthen innovation preparation R&D and CRO service capabilities.
Quality Foundation, Global Certification
Keyuan Pharmaceutical integrates the concept of "quality is life" into the entire industrial chain and has established a "market-oriented, internationally aligned quality management system" to ensure that every product meets high standards from R&D to delivery. With a comprehensive and rigorous quality management system, Keyuan Pharmaceutical has won widespread recognition in domestic and international markets. Its core products have successively passed international authoritative certifications such as US FDA, EU CEP, and Korea MFDS, providing safe and reliable products and services to global customers, truly realizing the company's commitment of "guarding life with quality."
Green Manufacturing, Global Layout
The company deeply implements the "five-force strategy"—using product strength to consolidate the foundation, innovation strength to drive development, quality strength to build reputation, delivery strength to win trust, and sustainability to lead the future—continuously empowering global market expansion and creating a highly efficient and agile delivery network. In the future, the company will accelerate its international strategic layout, serving the global life and health industry with a diversified product matrix, and strive to become a sustainable pharmaceutical enterprise with international competitiveness.
Keyuan Pharmaceutical—guarding health with technology, creating the future with symbiosis! The company will continue to cultivate the domestic market, accelerate the expansion of its global business map, comprehensively enhance its brand value and international influence, and continuously inject new vitality into the global life and health industry! Keyuan Pharmaceutical is not only an explorer of pharmaceutical technology but also a creator of a healthy future.
High-tech enterprise
Jinan Green Factory
Top 50 Sci-Tech Innovative Private Enterprises in Jinan
Jinan City New and Old Kinetic Energy Conversion Public Training Base
National drug standard of ammonia
National drug standard for methylcobalamin
National drug standard for lansoprazole
National drug standard for 2,4-dichlorophenoxyacetic acid
National drug standard for clarithromycin lactate
National drug standard for Fluoxetine Hydrochloride
2023 Shandong Province's Second Batch of Technological Innovation Projects -- (Paotaisong, nifedipine)
2023 Shandong Province's first batch of technological innovation projects -- (Furosemide)
2022 Shandong Province's Second Batch of Technological Innovation Projects -- (Qu Pi Bu Tong)
2022 Shandong Province's first batch of technological innovation projects -- (Esmolol hydrochloride)
2021 Shandong Province's Second Batch of Technological Innovation Projects -- (Ruxolitinib Hydrochloride, Propafenone Hydrochloride)
2021 Shandong Province's first batch of technological innovation projects -- (potassium diclofenac)